Titan Pharmaceuticals Inc Stock Ownership - Who owns Titan Pharmaceuticals?

Insider buying vs selling

Have Titan Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when TTNP insiders and whales buy or sell their stock.

TTNP Shareholders

What type of owners hold Titan Pharmaceuticals Inc stock?
Sire Group Ltd2,279.10%20,836,266$108.35MInsider
Pharmaceuticals Bvba Sprl Braeburn1,055.53%9,650,000$50.18MInsider
Choon Hau Choong415.88%3,802,100$19.77MInsider
Federico Seghi Recli87.60%800,845$4.16MInsider
Sunil Bhonsle66.95%612,050$3.18MInsider
Marc Rubin60.85%556,317$2.89MInsider
Louis R. Md Bucalo60.16%550,000$2.86MInsider
Joachim Friedrich Kapp59.76%546,339$2.84MInsider
Robert Edward Farrell35.07%320,580$1.67MInsider
Joseph A. Akers23.30%213,000$1.11MInsider

1 of 3

TTNP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LIXT2.45%97.55%Net Buying
OGEN0.47%99.53%Net Selling

Titan Pharmaceuticals Stock Ownership FAQ

Who owns Titan Pharmaceuticals?

Titan Pharmaceuticals (NASDAQ: TTNP) is owned by 3.51% institutional shareholders, 4,288.06% Titan Pharmaceuticals insiders, and 0.00% retail investors. Sire Group Ltd is the largest individual Titan Pharmaceuticals shareholder, owning 20.84M shares representing 2,279.10% of the company. Sire Group Ltd's Titan Pharmaceuticals shares are currently valued at $118.14M.

If you're new to stock investing, here's how to buy Titan Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.